| Year |
Citation |
Score |
| 2020 |
Hyrich KL, Gianfrancesco M, Machado PM, Yazdany J, Robinson PC. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo . Annals of the Rheumatic Diseases. PMID 32895239 DOI: 10.1136/Annrheumdis-2020-218910 |
0.393 |
|
| 2020 |
Gianfrancesco M, Yazdany J, Robinson PC. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases. Current Opinion in Rheumatology. PMID 32675715 DOI: 10.1097/Bor.0000000000000725 |
0.313 |
|
| 2020 |
Briggs FBS, Gianfrancesco MA, George MF. More on Covid-19 in Immune-Mediated Inflammatory Diseases. The New England Journal of Medicine. 383. PMID 32649070 DOI: 10.1056/NEJMc2018011#sa3 |
0.615 |
|
| 2020 |
Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. PMID 32471903 DOI: 10.1136/Annrheumdis-2020-217871 |
0.358 |
|
| 2020 |
Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases. PMID 32381561 DOI: 10.1136/Annrheumdis-2020-217690 |
0.305 |
|
| 2020 |
Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, et al. Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Nature Communications. 11: 1164. PMID 32109229 DOI: 10.1038/S41467-020-15097-Z |
0.519 |
|
| 2019 |
Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, et al. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Nature Communications. 10: 3902. PMID 31467281 DOI: 10.1038/S41467-019-11845-Y |
0.576 |
|
| 2019 |
Paranjpe I, Lanata C, Nititham J, Taylor K, Gianfrancesco MA, Paranjpe M, Andrews S, Chung S, Rhead B, Barcellos L, Trupin L, Katz P, DallEra MC, Yazdany J, Sirota M, et al. 149 Network-based analysis of clinical and molecular data in a multiethnic lupus cohort identifies molecular associations with serological manifestations Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.149 |
0.538 |
|
| 2018 |
Schmajuk G, Jafri K, Evans M, Shiboski S, Gianfrancesco M, Izadi Z, Patterson SL, Aggarwal I, Sarkar U, Dudley RA, Yazdany J. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. Seminars in Arthritis and Rheumatism. PMID 30449650 DOI: 10.1016/J.Semarthrit.2018.10.018 |
0.336 |
|
| 2018 |
Mowry EM, Hedström AK, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Bellesis KH, Briggs FBS, Olsson T, Alfredsson L, Barcellos LF. Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis. Multiple Sclerosis and Related Disorders. 24: 135-141. PMID 30005356 DOI: 10.1016/j.msard.2018.06.009 |
0.597 |
|
| 2018 |
Lanata C, Paranjpe I, Nititham J, Taylor K, Rhead B, Gianfrancesco M, Barcellos L, Murphy L, Katz P, Dall’Era M, Yazdany J, Sirota M, Criswell L. GG-06 Integrative analysis of multi-omics data in an ethnically diverse lupus cohort identifies distinct molecular subtypes of SLE Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.93 |
0.55 |
|
| 2017 |
Jafri K, Ogdie A, Qasim A, Patterson SL, Gianfrancesco M, Izadi Z, Katz P, Yazdany J, Schmajuk G. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Clinical Rheumatology. PMID 28993952 DOI: 10.1007/S10067-017-3860-X |
0.365 |
|
| 2017 |
Marshall DA, MacDonald KV, Robinson JO, Barcellos LF, Gianfrancesco M, Helm M, McGuire A, Green RC, Douglas MP, Goldman MA, Phillips KA. The price of whole-genome sequencing may be decreasing, but who will be sequenced? Personalized Medicine. 14: 203-211. PMID 28993792 DOI: 10.2217/Pme-2016-0075 |
0.484 |
|
| 2017 |
Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, et al. Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517733551. PMID 28980494 DOI: 10.1177/1352458517733551 |
0.583 |
|
| 2017 |
Hedström AK, Katsoulis M, Hössjer O, Bomfim IL, Oturai A, Sondergaard HB, Sellebjerg F, Ullum H, Thørner LW, Gustavsen MW, Harbo HF, Obradovic D, Gianfrancesco MA, Barcellos LF, Schaefer CA, et al. The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement. European Journal of Epidemiology. PMID 28597127 DOI: 10.1007/S10654-017-0250-2 |
0.568 |
|
| 2017 |
Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. PMID 28356466 DOI: 10.1212/Wnl.0000000000003849 |
0.568 |
|
| 2017 |
Gianfrancesco MA, Glymour MM, Walter S, Rhead B, Shao X, Shen L, Quach H, Hubbard A, Jónsdóttir I, Stefánsson K, Strid P, Hillert J, Hedström A, Olsson T, Kockum I, et al. Causal Effect of Genetic Variants Associated With Body Mass Index on Multiple Sclerosis Susceptibility. American Journal of Epidemiology. PMID 28073764 DOI: 10.1093/aje/kww120 |
0.624 |
|
| 2016 |
Gianfrancesco MA, Barcellos LF. Obesity and Multiple Sclerosis Susceptibility: A Review. Journal of Neurology & Neuromedicine. 1: 1-5. PMID 27990499 |
0.593 |
|
| 2016 |
Rhead B, Bäärnhielm M, Gianfrancesco M, Mok A, Shao X, Quach H, Shen L, Schaefer C, Link J, Gyllenberg A, Hedström AK, Olsson T, Hillert J, Kockum I, Glymour MM, et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurology. Genetics. 2: e97. PMID 27652346 DOI: 10.1212/Nxg.0000000000000097 |
0.599 |
|
| 2016 |
George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, et al. Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. Neurology. Genetics. 2: e87. PMID 27540591 DOI: 10.1212/Nxg.0000000000000087 |
0.707 |
|
| 2016 |
Gianfrancesco MA, Balzer L, Taylor KE, Trupin L, Nititham J, Seldin MF, Singer AW, Criswell LA, Barcellos LF. Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation. Genes and Immunity. PMID 27467283 DOI: 10.1038/Gene.2016.33 |
0.355 |
|
| 2016 |
Hedström AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Olsson T, Barcellos LF, Alfredsson L. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26940586 DOI: 10.1136/Jnnp-2015-312176 |
0.614 |
|
| 2014 |
Gianfrancesco MA, Acuna B, Shen L, Briggs FB, Quach H, Bellesis KH, Bernstein A, Hedstrom AK, Kockum I, Alfredsson L, Olsson T, Schaefer C, Barcellos LF. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obesity Research & Clinical Practice. 8: e435-47. PMID 25263833 DOI: 10.1016/j.orcp.2014.01.002 |
0.708 |
|
| 2014 |
Hedström AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, Olsson T, Alfredsson L. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 82: 865-72. PMID 24500647 DOI: 10.1212/Wnl.0000000000000203 |
0.617 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Gianfrancesco MA, Glicksberg BS, Dahl A, Lanata C, Kay J, Nititham J, Taylor K, Paranjpe I, Zaitlen N, Sirota M, Criswell L, Schmajuk G, Yazdany J. BD-06 Identification of systemic lupus erythematosus subgroups using electronic health record and genetic databases Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.30 |
0.289 |
|
| 2023 |
Yazdany J, Ware A, Wallace ZS, Bhana S, Grainger R, Hachulla E, Richez C, Cacoub P, Hausmann JS, Liew JW, Sirotich E, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, ... ... Gianfrancesco MA, et al. Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People with Rheumatic Diseases. Arthritis Care & Research. PMID 37643903 DOI: 10.1002/acr.25220 |
0.288 |
|
| 2020 |
Konig MF, Gianfrancesco M, Yazdany J, Robinson PC. Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon . Annals of the Rheumatic Diseases. PMID 32475834 DOI: 10.1136/Annrheumdis-2020-217990 |
0.272 |
|
| 2020 |
Anastasiou C, Trupin L, Glidden DV, Li J, Gianfrancesco M, Shiboski S, Schmajuk G, Yazdany J. Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016. Arthritis Care & Research. PMID 32558160 DOI: 10.1002/Acr.24356 |
0.268 |
|
| 2018 |
Gensler LS, Gianfrancesco M, Weisman MH, Brown MA, Lee M, Learch T, Rahbar M, Reveille JD, Ward MM. OP0198 Combined effects of tumour necrosis factor inhibitors and nsaids on radiographic progression in ankylosing spondylitis Annals of the Rheumatic Diseases. 77: 148-148. DOI: 10.1136/Annrheumdis-2018-Eular.4027 |
0.267 |
|
| 2020 |
Gianfrancesco M, Hyrich KL, Yazdany J, Machado PM, Robinson PC. Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi . Annals of the Rheumatic Diseases. PMID 32606045 DOI: 10.1136/Annrheumdis-2020-218328 |
0.262 |
|
| 2019 |
Gandrup J, Li J, Izadi Z, Gianfrancesco M, Ellingsen T, Yazdany J, Schmajuk G. Three Quality Improvement Initiatives Improved Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results from an Interrupted Time Series Study. Arthritis Care & Research. PMID 30740931 DOI: 10.1002/Acr.23848 |
0.256 |
|
| 2021 |
Schmajuk G, Montgomery AD, Leonard S, Li J, Gianfrancesco M, Seet A, Izadi Z, Yazdany J, Keyhani S. Factors Associated With Hospitalization and Death After COVID-19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data. Acr Open Rheumatology. PMID 34423917 DOI: 10.1002/acr2.11328 |
0.256 |
|
| 2021 |
Liew JW, Gianfrancesco MA, Heckbert SR, Gensler LS. The relationship between body mass index, disease activity, and exercise in ankylosing spondylitis. Arthritis Care & Research. PMID 33502113 DOI: 10.1002/acr.24565 |
0.254 |
|
| 2019 |
Patterson S, Schmajuk G, Evans M, Aggarwal I, Izadi Z, Gianfrancesco M, Yazdany J. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. Joint Commission Journal On Quality and Patient Safety. PMID 30686706 DOI: 10.1016/J.Jcjq.2018.12.003 |
0.25 |
|
| 2019 |
Izadi Z, Gianfrancesco M, Evans M, Kay J, Trupin L, Schmajuk G, Petri MA, Yazdany J. Op0263 Hydroxychloroquine Dosing In Patients With Rheumatic Disease Across The U.S.: Data From The Rheumatology Informatics System For Effectiveness (Rise) Registry Annals of the Rheumatic Diseases. 78: 212-213. DOI: 10.1136/Annrheumdis-2019-Eular.5119 |
0.249 |
|
| 2022 |
Izadi Z, Gianfrancesco MA, Schmajuk G, Jacobsohn L, Katz P, Rush S, Ja C, Taylor T, Shidara K, Danila MI, Wysham KD, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, et al. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study. The Lancet. Rheumatology. PMID 35909441 DOI: 10.1016/S2665-9913(22)00192-8 |
0.245 |
|
| 2018 |
Izadi Z, Katz PP, Schmajuk G, Gandrup J, Li J, Gianfrancesco M, Yazdany J. Effects of language, insurance and race/ethnicity on measurement properties of the PROMIS Physical Function Short Form 10a in rheumatoid arthritis. Arthritis Care & Research. PMID 30099861 DOI: 10.1002/Acr.23723 |
0.242 |
|
| 2018 |
Li J, Yazdany J, Trupin L, Izadi Z, Gianfrancesco M, Goglin S, Schmajuk G. Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study. Jmir Medical Informatics. 6: e31. PMID 29743158 DOI: 10.2196/Medinform.8687 |
0.241 |
|
| 2011 |
Gianfrancesco MA, Triche EW, Fawcett JA, Labas MP, Patterson TS, Lo AC. Speed- and cane-related alterations in gait parameters in individuals with multiple sclerosis Gait and Posture. 33: 140-142. PMID 20952198 DOI: 10.1016/J.Gaitpost.2010.09.016 |
0.232 |
|
| 2020 |
Izadi Z, Schmajuk G, Gianfrancesco M, Subash M, Evans M, Trupin L, Yazdany J. Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures. Arthritis Care & Research. PMID 32937026 DOI: 10.1002/Acr.24444 |
0.226 |
|
| 2020 |
Ying D, Gianfrancesco MA, Trupin L, Yazdany J, Greidinger EL, Schmajuk G. Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans. The Journal of Rheumatology. 47: 82-88. PMID 30877213 DOI: 10.3899/jrheum.181311 |
0.223 |
|
| 2021 |
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, et al. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. Jama Network Open. 4: e2129639. PMID 34661663 DOI: 10.1001/jamanetworkopen.2021.29639 |
0.208 |
|
| 2022 |
Izadi Z, Gianfrancesco MA, Aguirre A, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Seet AM, Schmajuk G, Jacobsohn L, Katz P, et al. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. Acr Open Rheumatology. PMID 35869686 DOI: 10.1002/acr2.11481 |
0.206 |
|
| 2021 |
Taylor T, Yazdany J, Gianfrancesco MA. The racial/ethnic and sociocultural aspects of the pandemic in rheumatology. Best Practice & Research. Clinical Rheumatology. 101665. PMID 33648855 DOI: 10.1016/j.berh.2021.101665 |
0.199 |
|
| 2020 |
Norgeot B, Quer G, Beaulieu-Jones BK, Torkamani A, Dias R, Gianfrancesco M, Arnaout R, Kohane IS, Saria S, Topol E, Obermeyer Z, Yu B, Butte AJ. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nature Medicine. 26: 1320-1324. PMID 32908275 DOI: 10.1038/S41591-020-1041-Y |
0.197 |
|
| 2020 |
Gianfrancesco M, Hyrich KL, Yazdany J, Machado PM, Robinson PC. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M by Andreica and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin . Annals of the Rheumatic Diseases. PMID 32796043 DOI: 10.1136/annrheumdis-2020-218713 |
0.189 |
|
| 2021 |
Gianfrancesco MA, Crowson CS. Where There's Smoke, There's a Joint: Passive Smoking and Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34347946 DOI: 10.1002/art.41940 |
0.189 |
|
| 2020 |
Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, et al. Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33146001 DOI: 10.1002/art.41567 |
0.187 |
|
| 2019 |
Gianfrancesco MA, Briggs FBS. Does early high body mass index influence onset of pediatric multiple sclerosis? Developmental Medicine and Child Neurology. PMID 31044421 DOI: 10.1111/dmcn.14255 |
0.187 |
|
| 2021 |
Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. PMID 33504483 DOI: 10.1136/annrheumdis-2020-219498 |
0.186 |
|
| 2022 |
Yeoh SA, Gianfrancesco M, Lawson-Tovey S, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Schäfer M, Richez C, Hachulla E, Holmqvist M, Scirè CA, Lorenz HM, Voll RE, et al. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Rmd Open. 8. PMID 36100295 DOI: 10.1136/rmdopen-2022-002508 |
0.184 |
|
| 2022 |
Ugarte-Gil MF, Alarcón GS, Seet AM, Izadi Z, Montgomery AD, Duarte-García A, Gilbert EL, Valenzuela-Almada MO, Wise L, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Sirotich E, Liew JW, ... ... Gianfrancesco M, et al. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus (SLE) Patients from the United States: Data from the COVID-19 Global Rheumatology Alliance. Arthritis Care & Research. PMID 36239292 DOI: 10.1002/acr.25039 |
0.177 |
|
| 2017 |
Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Adams Dudley R, Yazdany J. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Rheumatology International. PMID 28748425 DOI: 10.1007/s00296-017-3782-6 |
0.174 |
|
| 2021 |
Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, et al. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. The Lancet. Rheumatology. PMID 34778843 DOI: 10.1016/S2665-9913(21)00316-7 |
0.173 |
|
| 2022 |
Taylor T, Anastasiou C, Ja C, Rush S, Trupin L, Dall'Era M, Katz P, Barbour KE, Greenlund KJ, Yazdany J, Gianfrancesco MA. Causes of death among individuals with systemic lupus erythematosus by race and ethnicity: a population-based study. Arthritis Care & Research. PMID 35904969 DOI: 10.1002/acr.24988 |
0.17 |
|
| 2021 |
Hyrich KL, Schäfer M, Strangfeld A, Carmona L, Gossec L, Mateus EF, Lawson-Tovey S, Gianfrancesco M, Robinson PC, Yazdany J, Machado PM. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum . Annals of the Rheumatic Diseases. PMID 33985941 DOI: 10.1136/annrheumdis-2021-220613 |
0.169 |
|
| 2021 |
Schäfer M, Strangfeld A, Hyrich KL, Carmona L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Gossec L, Robinson PC, Yazdany J, Machado PM. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn . Annals of the Rheumatic Diseases. PMID 33648957 DOI: 10.1136/annrheumdis-2021-220134 |
0.169 |
|
| 2021 |
Machado PM, Schäfer M, Strangfeld A, Gossec L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Carmona L, Hyrich KL, Robinson PC, Yazdany J. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers. Annals of the Rheumatic Diseases. PMID 33602795 DOI: 10.1136/annrheumdis-2021-220058 |
0.169 |
|
| 2018 |
Gianfrancesco MA, Yazdany J, Schmajuk G. The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding. Rheumatology International. 38: 313-314. PMID 29209792 DOI: 10.1007/s00296-017-3902-3 |
0.167 |
|
| 2019 |
Gianfrancesco MA, Trupin L, McCulloch CE, Shiboski S, Schmajuk G, Yazdany J. Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data. Acr Open Rheumatology. 1: 113-118. PMID 31777787 DOI: 10.1002/acr2.1017 |
0.159 |
|
| 2018 |
Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, Yazdany J, Schmajuk G. Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates. The Journal of Rheumatology. 46: 370-375. PMID 30504507 DOI: 10.3899/jrheum.180262 |
0.159 |
|
| 2020 |
Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology. PMID 32309814 DOI: 10.1016/S2665-9913(20)30095-3 |
0.158 |
|
| 2021 |
Gianfrancesco MA, Dall'Era M, Murphy LB, Helmick CG, Li J, Rush S, Trupin L, Yazdany J. Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017. Mmwr. Morbidity and Mortality Weekly Report. 70: 236-239. PMID 33600382 DOI: 10.15585/mmwr.mm7007a2 |
0.158 |
|
| 2022 |
Ugarte-Gil MF, Alarcón GS, Izadi Z, Duarte-García A, Reátegui-Sokolova C, Clarke AE, Wise L, Pons-Estel GJ, Santos MJ, Bernatsky S, Ribeiro SLE, Al Emadi S, Sparks JA, Hsu TY, Patel NJ, ... ... Gianfrancesco M, et al. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Annals of the Rheumatic Diseases. PMID 35172961 DOI: 10.1136/annrheumdis-2021-221636 |
0.158 |
|
| 2021 |
Gianfrancesco MA, Robinson PC. Changing COVID-19 outcomes in patients with rheumatic disease-are we really getting better at this? The Lancet. Rheumatology. 3: e88-e90. PMID 33655223 DOI: 10.1016/S2665-9913(21)00008-4 |
0.149 |
|
| 2021 |
Hammam N, Li J, Evans M, Kay JL, Izadi Z, Anastasiou C, Gianfrancesco MA, Yazdany J, Schmajuk G. Epidemiology and treatment of Behçet's disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions. Arthritis Research & Therapy. 23: 224. PMID 34461986 DOI: 10.1186/s13075-021-02615-7 |
0.147 |
|
| 2021 |
Bermas BL, Gianfrancesco M, Tanner HL, Seet AM, Aguiar MC, Al Adhoubi NK, Emadi SA, Cunha BM, Flood R, Kusevich DA, McCarthy EM, Patel NJ, Ruderman E, Sattui SE, Sciascia S, et al. COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance. The Journal of Rheumatology. PMID 34470798 DOI: 10.3899/jrheum.210480 |
0.145 |
|
| 2021 |
Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, et al. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Annals of the Rheumatic Diseases. PMID 34049860 DOI: 10.1136/annrheumdis-2021-220418 |
0.136 |
|
| 2020 |
Gianfrancesco MA, McCulloch CE, Trupin L, Graf J, Schmajuk G, Yazdany J. Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study. Annals of Epidemiology. PMID 32807591 DOI: 10.1016/J.Annepidem.2020.06.008 |
0.133 |
|
| 2019 |
Norgeot B, Glicksberg BS, Trupin L, Lituiev D, Gianfrancesco M, Oskotsky B, Schmajuk G, Yazdany J, Butte AJ. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis. Jama Network Open. 2: e190606. PMID 30874779 DOI: 10.1001/jamanetworkopen.2019.0606 |
0.118 |
|
| 2010 |
Lo AC, Chang VC, Gianfrancesco MA, Friedman JH, Patterson TS, Benedicto DF. Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: A pilot study Journal of Neuroengineering and Rehabilitation. 7. PMID 20946640 DOI: 10.1186/1743-0003-7-51 |
0.111 |
|
| 2021 |
Gianfrancesco MA, Goldstein ND. A narrative review on the validity of electronic health record-based research in epidemiology. Bmc Medical Research Methodology. 21: 234. PMID 34706667 DOI: 10.1186/s12874-021-01416-5 |
0.105 |
|
| 2022 |
Jatuworapruk K, Montgomery A, Gianfrancesco M, Conway R, Durcan L, Graef ER, Jayatilleke A, Keen H, Kilian A, Young K, Carmona L, Cogo AK, Duarte-García A, Gossec L, Hasseli R, et al. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. Acr Open Rheumatology. PMID 36000538 DOI: 10.1002/acr2.11495 |
0.097 |
|
| 2022 |
Maguire S, Al-Emadi S, Alba P, Aguiar MC, Lawati TA, Alle G, Bermas B, Bhana S, Branimir A, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, ... ... Gianfrancesco M, et al. Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status. Rheumatology (Oxford, England). PMID 36124987 DOI: 10.1093/rheumatology/keac534 |
0.097 |
|
| 2017 |
Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Dudley RA, Yazdany J. Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Rheumatology International. PMID 29273937 DOI: 10.1007/s00296-017-3918-8 |
0.071 |
|
| 2022 |
Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, et al. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. Rmd Open. 8. PMID 35387864 DOI: 10.1136/rmdopen-2021-002187 |
0.069 |
|
| 2022 |
Humbert-Droz M, Izadi Z, Schmajuk G, Gianfrancesco M, Baker MC, Yazdany J, Tamang S. Development of a natural language processing system for extracting rheumatoid arthritis outcomes from clinical notes using the national RISE registry. Arthritis Care & Research. PMID 35157365 DOI: 10.1002/acr.24869 |
0.064 |
|
| 2023 |
Tamang S, Humbert-Droz M, Gianfrancesco M, Izadi Z, Schmajuk G, Yazdany J. Practical Considerations for Developing Clinical Natural Language Processing Systems for Population Health Management and Measurement. Jmir Medical Informatics. 11: e37805. PMID 36595345 DOI: 10.2196/37805 |
0.062 |
|
| 2020 |
Gianfrancesco MA. Initial data from the COVID-19 Global Rheumatology Alliance provider registries - Authors' reply. The Lancet. Rheumatology. 2: e317. PMID 32377642 DOI: 10.1016/S2665-9913(20)30125-9 |
0.053 |
|
| 2018 |
Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. Jama Internal Medicine. PMID 30128552 DOI: 10.1001/jamainternmed.2018.3763 |
0.045 |
|
| Hide low-probability matches. |